Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
October 23, 2026 0.3991
October 22, 2026 0.3814
October 21, 2026 0.3874
October 20, 2026 0.4007
October 19, 2026 0.4007
October 16, 2026 0.3895
October 15, 2026 0.4157
October 14, 2026 0.4296
October 13, 2026 0.4296
October 12, 2026 0.4167
October 09, 2026 0.4296
October 08, 2026 0.4296
October 07, 2026 0.436
October 06, 2026 0.4257
October 05, 2026 0.4256
October 02, 2026 0.4276
October 01, 2026 0.4208
September 30, 2026 0.4256
September 29, 2026 0.394
September 28, 2026 0.4103
September 25, 2026 0.3959
September 24, 2026 0.4135
September 23, 2026 0.4135
September 22, 2026 0.4207
September 21, 2026 0.419
Date Value
September 18, 2026 0.4103
September 17, 2026 0.4111
September 16, 2026 0.4416
September 15, 2026 0.4577
September 14, 2026 0.4577
September 11, 2026 0.4689
September 10, 2026 0.4617
September 09, 2026 0.4641
September 08, 2026 0.477
September 04, 2026 0.4601
September 03, 2026 0.4727
September 02, 2026 0.4826
September 01, 2026 0.4731
August 31, 2026 0.4802
August 28, 2026 0.4435
August 27, 2026 0.443
August 26, 2026 0.4368
August 25, 2026 0.4657
August 24, 2026 0.477
August 21, 2026 0.4681
August 20, 2026 0.4818
August 19, 2026 0.4681
August 18, 2026 0.4707
August 17, 2026 0.4336
August 14, 2026 0.4432

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 2.793
Corcept Therapeutics, Inc. 13.13
Veru, Inc. 1.346
Johnson & Johnson 7.789
Eli Lilly & Co. 35.39

Price to Book Value Related Metrics

Price 4.97
Earnings Yield -474.7%
Market Cap 7.263M